STAT+: Pharmalittle: FDA panel votes against Lilly cancer drug over China data; Biogen makes Medicare a counteroffer

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, once again, is exceedingly modest. We plan to catch up on our reading, promenade with the official mascot, and take naps. And what about you? This is a fine time to enjoy the great outdoors — a brisk walk in the park, a run down on a slope, or a trek through the woods is good for the soul. You could also stock up on all sorts of sundry goods before prices climb still further. Or you could touch base with an older someone who feels a bit isolated these days. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

A panel advising the U.S. Food and Drug Administration decided…
Click here to view original post